Not available
Quote | CASI Pharmaceuticals Inc. (NASDAQ:CASI)
Last: | $2.44 |
---|---|
Change Percent: | 0.0% |
Open: | $2.51 |
Close: | $2.44 |
High: | $2.58 |
Low: | $2.44 |
Volume: | 9,117 |
Last Trade Date Time: | 04/24/2024 03:00:00 am |
News | CASI Pharmaceuticals Inc. (NASDAQ:CASI)
CASI PHARMACEUTICALS REPORTS DEVELOPMENT RELATING TO ITS DISPUTES WITH JUVENTAS PR Newswire BEIJING , April 8, 2024 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a Cayman incorporated biopharmaceutical company focused on developing and commercia...
2024-03-28 12:53:18 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips CASI Pharmaceuticals (NASDAQ: CASI ) just reported results for the fourth quarter of 2023. CASI Pharmaceuticals reported earnings per share of -45 cents. This was below th...
Message Board Posts | CASI Pharmaceuticals Inc. (NASDAQ:CASI)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $CASI News Article - CASI PHARMACEUTICALS ANNOUNCES SECOND QUARTER 2022 FINANCIAL RESUL | whytestocks | investorshangout | 08/12/2022 12:01:14 PM |
znewcar1: CASI 29% v5,1M c3.90 f13,6M H4.73 ML2.24 YL2.28 | znewcar1 | investorshangout | 08/12/2022 1:54:57 AM |
whytestocks: $CASI News Article - CASI PHARMACEUTICALS ANNOUNCES REVERSE STOCK SPLIT | whytestocks | investorshangout | 05/26/2022 8:37:00 PM |
whytestocks: $CASI News Article - CASI PHARMACEUTICALS ANNOUNCES STOCK REPURCHASE PROGRAM | whytestocks | investorshangout | 12/17/2021 4:30:50 PM |
Nice pop afterhours. | Ichauway | investorshub | 11/20/2021 3:12:59 AM |
News, Short Squeeze, Breakout and More Instantly...
CASI Pharmaceuticals Inc. Company Name:
CASI Stock Symbol:
NASDAQ Market:
CASI Pharmaceuticals Inc. Website:
CASI PHARMACEUTICALS REPORTS DEVELOPMENT RELATING TO ITS DISPUTES WITH JUVENTAS PR Newswire BEIJING , April 8, 2024 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a Cayman incorporated biopharmaceutical company focused on developing and commercia...
CASI PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2023 BUSINESS AND FINANCIAL RESULTS PR Newswire BEIJING , March 28, 2024 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a Cayman incorporated biopharmaceutical company focused on developing a...